<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30448897</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1573-7217</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Breast cancer research and treatment</Title>                <ISOAbbreviation>Breast Cancer Res. Treat.</ISOAbbreviation>            </Journal>            <ArticleTitle>Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-018-5048-8</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Long-term disease-free survival patterns following surgical, radiation, and endocrine therapy treatments for ductal carcinoma in situ (DCIS) are not well characterized in general US practice.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We identified 1252 women diagnosed with DCIS in Vermont during 1994-2012 using data from the Vermont Breast Cancer Surveillance System, a statewide registry of breast imaging and pathology records. Poisson regression and Cox regression with time-varying hazards were used to evaluate disease-free survival among self-selected treatment groups.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">With 7.8 years median follow-up, 192 cases experienced a second breast cancer diagnosis. For women treated with breast-conserving surgery (BCS) alone, the annual rate of second events decreased from 3.1% (95% CI 2.2-4.2%) during follow-up years 1-5 to 1.7% (95% CI 0.7-3.5%) after 10 years. In contrast, the annual rate of second events among women treated with BCS plus adjuvant radiation therapy increased from 1.8% (95% CI 1.1-2.6%) during years 1-5 to 2.8% (95% CI 1.6-4.7%) after 10 years (P &lt; 0.05 for difference in trend compared to BCS alone). Annual rates of second events also increased over time among women treated with BCS plus adjuvant radiation and endocrine therapy (P = 0.01 for difference in trend compared to BCS alone). The rate of contralateral events increased after 10 years for all groups with adjuvant treatments. The rate of second events did not vary over time among women who underwent ipsilateral mastectomy (P = 0.62).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Long-term risk of a second event after DCIS varies over time in a manner dependent on initial treatment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sprague</LastName>                    <ForeName>Brian L</ForeName>                    <Initials>BL</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7948-8317</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, University of Vermont, 1 S. Prospect St, UHC Room 4425, Burlington, VT, 05401, USA. brian.sprague@uvm.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, University of Vermont, Burlington, VT, USA. brian.sprague@uvm.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA. brian.sprague@uvm.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vacek</LastName>                    <ForeName>Pamela M</ForeName>                    <Initials>PM</Initials>                    <AffiliationInfo>                        <Affiliation>University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medical Biostatistics Unit, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Herschorn</LastName>                    <ForeName>Sally D</ForeName>                    <Initials>SD</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>James</LastName>                    <ForeName>Ted A</ForeName>                    <Initials>TA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Geller</LastName>                    <ForeName>Berta M</ForeName>                    <Initials>BM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Family Medicine, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Trentham-Dietz</LastName>                    <ForeName>Amy</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Stein</LastName>                    <ForeName>Janet L</ForeName>                    <Initials>JL</Initials>                    <AffiliationInfo>                        <Affiliation>University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Biochemistry, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weaver</LastName>                    <ForeName>Donald L</ForeName>                    <Initials>DL</Initials>                    <AffiliationInfo>                        <Affiliation>University of Vermont Cancer Center, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, University of Vermont, Burlington, VT, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>U01 CA196383</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>U54 CA163303</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>P01 CA154292</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>PCS-1504-30370</GrantID>                    <Agency>Patient-Centered Outcomes Research Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>032800</GrantID>                    <Agency>University of Vermont Cancer Center</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Breast Cancer Res Treat</MedlineTA>            <NlmUniqueID>8111104</NlmUniqueID>            <ISSNLinking>0167-6806</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Cohort studies</Keyword>            <Keyword MajorTopicYN="N">Disease-free survival</Keyword>            <Keyword MajorTopicYN="N">Ductal carcinoma in situ</Keyword>            <Keyword MajorTopicYN="N">Treatment outcome</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>11</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30448897</ArticleId>            <ArticleId IdType="doi">10.1007/s10549-018-5048-8</ArticleId>            <ArticleId IdType="pii">10.1007/s10549-018-5048-8</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>